Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kenemans

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
Clinical Chemistry|December 1, 1987
Time-resolved immunofluorometric assay for the ovarian carcinoma-associated antigenic determinant CA 125 in serumO C Boerman, C M Thomas, M F Segers, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 1998
'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequenceD J Schol, M F Meulenbroek, F G Snijdewint, et al.
Gynecologic Oncology|May 8, 1998
Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter studyE M Schutter, C Sohn, P Kristen, et al.
Cancer|August 15, 1994
Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter studyE M Schutter, P Kenemans, C Sohn, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptidesH W Nijman, J G Houbiers, S H van der Burg, et al.
Gynecologic Oncology|December 1, 1994
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancerJ M Bonfrer, K N Gaarenstroom, G G Kenter, et al.
Nuclear Medicine Communications|December 1, 1992
Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancerJ G Tibben, L F Massuger, R A Claessens, et al.
European Journal of Clinical Investigation|August 23, 2002
Effects of hormone replacement therapy on blood plateletsA Thijs, W M van Baal, M J van der Mooren, et al.
Thrombosis and Haemostasis|October 4, 2002
Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trialM S Post, M J van der Mooren, C D A Stehouwer, et al.
Climacteric : the Journal of the International Menopause Society|September 28, 2011
Less mammographic density after nasal versus oral administration of postmenopausal hormone therapyJ A A M van Dijck, J D M Otten, N Karssemeijer, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
Clinical Chemistry|December 1, 1987
Time-resolved immunofluorometric assay for the ovarian carcinoma-associated antigenic determinant CA 125 in serumO C Boerman, C M Thomas, M F Segers, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 1998
'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequenceD J Schol, M F Meulenbroek, F G Snijdewint, et al.
Gynecologic Oncology|May 8, 1998
Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter studyE M Schutter, C Sohn, P Kristen, et al.
Cancer|August 15, 1994
Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter studyE M Schutter, P Kenemans, C Sohn, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptidesH W Nijman, J G Houbiers, S H van der Burg, et al.
Gynecologic Oncology|December 1, 1994
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancerJ M Bonfrer, K N Gaarenstroom, G G Kenter, et al.
Nuclear Medicine Communications|December 1, 1992
Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancerJ G Tibben, L F Massuger, R A Claessens, et al.
European Journal of Clinical Investigation|August 23, 2002
Effects of hormone replacement therapy on blood plateletsA Thijs, W M van Baal, M J van der Mooren, et al.
Thrombosis and Haemostasis|October 4, 2002
Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trialM S Post, M J van der Mooren, C D A Stehouwer, et al.
Climacteric : the Journal of the International Menopause Society|September 28, 2011
Less mammographic density after nasal versus oral administration of postmenopausal hormone therapyJ A A M van Dijck, J D M Otten, N Karssemeijer, et al.
Pageof 24